Home

carboxylesterases

Carboxylesterases are a family of serine hydrolases that catalyze the hydrolysis of carboxylic esters, converting esters into an alcohol and a carboxylic acid. They act on a broad range of substrates, including endogenous lipid esters and many xenobiotic esters, making them important for both normal physiology and detoxification of foreign compounds. In humans the best characterized enzymes are CES1 and CES2, encoded by the CES1 and CES2 genes, which show distinct tissue distribution and substrate preferences.

Structure and mechanism: Carboxylesterases belong to the alpha/beta hydrolase fold and use a catalytic triad of

Expression and localization: CES1 is abundant in the liver and contributes to systemic drug metabolism, whereas

Physiological and pharmacological relevance: Carboxylesterases metabolize endogenous esters and activate or deactivate many drugs and prodrugs.

Research and clinical implications: Variability in CES activity is a consideration in drug development and personalized

serine,
histidine,
and
an
acidic
residue
(glutamate
or
aspartate).
The
active
serine
resides
in
a
conserved
motif
(a
serine-containing
GXSXG-like
sequence)
and
acts
as
a
nucleophile
to
attack
the
ester
linkage,
forming
an
acyl-enzyme
intermediate
that
is
then
hydrolyzed
to
release
products.
CES2
is
highly
expressed
in
the
small
intestine
and
also
participates
in
first-pass
metabolism.
Other
family
members,
such
as
CES3
and
CES5,
have
broader
tissue
distributions
in
various
species.
Examples
include
activation
of
oseltamivir
by
CES1
and
conversion
of
irinotecan
to
the
active
metabolite
SN-38
by
CES2;
CES1
also
hydrolyzes
certain
antiplatelet
prodrugs
like
clopidogrel
to
inactive
forms.
Genetic
polymorphisms
and
drug
interactions
can
significantly
affect
enzyme
activity,
influencing
efficacy
and
risk
of
adverse
effects.
therapy,
as
polymorphisms,
disease
states,
or
co-administered
inhibitors
can
alter
prodrug
activation
and
detoxification
of
esters.
Environmental
organophosphates
and
some
pesticides
are
known
inhibitors
of
carboxylesterases.